Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

World champion Andri Ragettli visits GF in Seewis together with students

As part of the 50[th] anniversary of GF Piping Systems in Seewis (Switzerland), Andri Ragettli, the freestyle world champion from nearby Flims, visited the production site together with a group of upper school students. With 170 employees, the modern plant produces plastic valves and actuators, including the new pressure regulating valve NeoFlow, for the effective prevention of water loss.At 2:00 p.m., Production Manager Stefano Ferramosca and Sandra Peng, Vocational Training Coordinator, welcomed the guests from the Gruesch and Landquart upper schools and the winner of the gold medal at

Bulletin from the Extraordinary General Meeting in Implantica AG – assets of EUR 117 million have been contributed to Implantica without monetary or share compensation

Today, September 17, 2021, the extraordinary general meeting (the “EGM”) of Implantica AG (publ) was held in Vaduz. The EGM resolved to adopt all of the board of directors’ resolution proposals, unanimously with no single shareholder voting against the proposals in Implantica AG or Implantica MediSwiss AG. A summary of the resolutions adopted at the extraordinary general meeting is set out below.The extraordinary general meeting resolved to approve the merger plan dated 17 August 2021 for the merger of Implantica MediSwiss AG as the transferring company into Implantica AG as the acquiring

Strangvac, a vaccine against equine strangles, has been granted marketing authorisation in the UK

Stockholm, September 17, 2021 - Intervacc AB (“Intervacc”) announced today that the Veterinary Medicines Directorate (VMD) of the United Kingdom has granted a Marketing Authorisation for Strangvac within the UK. Strangvac is a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally. “We are delighted that Strangvac has been granted a market authorisation in the UK” explained Andreas Andersson, CEO of Intervacc. “Up to 600 outbreaks of strangles occur in the UK each year, impacting thousands of horses and we feel a great responsibility to

MilliporeSigma Joins Cyclyx as Founding Member

· First Cyclyx member representing the life sciences industry · Membership demonstrates collaboration to develop innovative recycling solutions for post-use plasticsPORTSMOUTH, New Hampshire, USA, September 17, 2021 – Cyclyx International, a consortium-based feedstock management company with a mission to increase the recycling rate of plastic from 10% to 90%, has announced MilliporeSigma has joined the consortium as the newest founding member. MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company and supplier to the

Sandvik AB – Nomination Committee for the 2022 Annual General Meeting

In 2020 Sandvik AB’s Annual General Meeting adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprised of members appointed by each of the four principal shareholders in terms of votes on the last banking day of August, as well as the Chairman of the Board (convenor). The Nomination Committee has now been appointed and consists of the following members: · Fredrik Lundberg, AB Industrivärden, Chairman of the Nomination

SOTKAMO SILVER AB: NEW CHIEF FINANCIAL OFFICER

Press release: Stockholm, September 17, 2021 14:00 CETSotkamo Silver AB is pleased to announce the appointment of Mr. Tommi Talasterä as the new Chief Financial Officer (CFO) of the group companies. Mr. Talasterä has Master of Science degree from  Svenska Handelshögskolan in Helsinki, and he has previously served as CFO and Finance manager both in the mining industry, manufacturing and service sector. He will join Sotkamo Silver from the CFO position of Profile Vehicles, and will take up his position before the end of November 2021. Mikko Sopanen has decided to endeavour his career

Growing potential in soft mobility – myFC sees great opportunities for their patented fuel cell technology

Soft mobility –  such as cargo bikes, electric bikes, taxi pods, vehicles for last mile delivery and more – is a segment where myFC's scalable and malleable micro fuel cells provide important benefits. For instance, in terms of range, charging time, weight and space compared to conventional fuel cell solutions and pure battery operation.– We see a great and growing potential for our technology, says Michael Glantz, CEO of myFC.Mobility is a password of today. Climate change and strong urbanization have driven the need for smart, sustainable, and green transport solutions. A sign of the

Flowscape gets big new order

An existing large global customer, with more than 100,000 employees, has placed an order to expand Flowscape's room and desk booking solution to additional offices. The order value is MSEK 1,1 and includes both software and installation services.“We now see that several of our customers are opening up and returning to their offices globally. This customer will purchase additional licenses as the number of users of the system increases. Initially the installation for this customer was focusing only on room booking , but desk booking is now being launched across their offices globally. There

SelectImmune Pharma holds digital investor meeting

SelectImmune Pharma is offering a digital investors’ meeting via Zoom, on Thursday September 23[rd] at 12.00 CET. We welcome existing owners, other investors and interested parties to join. The meeting participants will be able to hear of the company developments and ask questions. These may be asked online in the meeting or be sent via e-mail to the addresses listed below. The meeting will be held in Swedish. Please use this link to participate: https://us06web.zoom.us/j/88543060204?pwd=djUzRDh6VU9LQ1A1MGpVSzB2a1U4UT09   For written questions, please contact: Catharina

Announcement from tbd30's annual general meeting

The annual general meeting of tbd30 AB ("tbd30" or the "Company") was held today on 17 September 2021 and the following resolutions were passed by the meeting.ADOPTION OF THE INCOME STATEMENT AND BALANCE SHEETThe annual general meeting resolved to adopt tbd30's income statement and balance sheet. DISTRIBUTION OF PROFITThe annual general meeting resolved to treat the result in accordance with the proposal of the board of directors in the annual report, meaning that the result is carried forward. DISCHARGE FROM LIABILITYThe directors and managing director were discharged from

Cereno Scientific obtains IND acceptance from FDA to start Phase II study with drug candidate CS1 in PAH

Cereno Scientific (XSAT: CRNO B) today announced that the US Food and Drug Administration (FDA) has accepted Cereno’s investigational new drug application (IND) for drug candidate CS1. This application was a collaborative effort with global partner Abbott for the IND opening study. The acceptance of the IND allows Cereno to start the planned Phase II study in patients with pulmonary arterial hypertension (PAH) at clinical sites in the US in accordance with the submitted study protocol.“This is a great milestone for the team and the company. We are excited to see our rare disease strategy

Enviro’s recovered oil and carbon black receive ISCC sustainability certification

The oil and carbon black that Scandinavian Enviro Systems recovers from end-of-life vehicle tyres in its plant in Åsensbruk have been accredited under the International Sustainability & Carbon Certification (ISCC) scheme.In doing so, Enviro has become the first company in the world to receive ISCC certification for recovered carbon black, and the certification is also confirmation of the previously communicated higher commercial values of both carbon black and oil.N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the

Bong in process to refinance its current bond

· Refinancing with a new bond in combination with bank loan · Reduction of debt from SEK 210 million to SEK 175 million · Commitment from several current bond holders to participate in new bondBong AB (publ) (the "Company") today announces that, in order to refinance its current bond, the company intend to issue a new bond in combination with a bank loan. The company has during the past 18 months made repurchases to the nominal amount of SEK 34.75 million which means that the amount to be refinanced is SEK 175.25 million. A senior secured bond will be issued to the amount of SEK 110

Tokmanni issues an important policy on the use of palm oil – All of Tokmanni’s private label products will contain only sustainably produced palm oil by the end of 2021

Tokmanni     Press release     17 September 2021 at 1:50 p.m. According to a policy issued by Tokmanni, Finland’s leading variety discount retailer, all its private label products will contain only sustainably produced palm oil by the end of this year. Tokmanni is also increasing the use of RSPO-certified palm oil in its technochemical private label products, such as cosmetics, detergents and cleaning products. With its policy, Tokmanni is further strengthening its long-term work to promote sustainability. The use of sustainably produced palm oil is extremely important because

Career story: “What motivates me most in my work is Planmeca’s mission: better care through innovation”

To celebrate Planmeca’s 50th anniversary, we are releasing a series of career stories from our incredible employees. These stories introduce some of the experts behind our pioneering dental innovations and show a glimpse behind the scenes at Planmeca headquarters in Helsinki. In this article, Test Development Manager Lauri Anttila describes how his aspiration for a meaningful job led him to study medical imaging and to work in test development at Planmeca. Who:Lauri Anttila, MHSc, Medical TechnologyTest Development Manager, X-ray divisionPlanmeca Oy Lauri Anttila came to

FDA pauses start of DIAGNODE-3 in the US pending clarification on study drug

The start of the Phase III trial DIAGNODE-3 in the United States is being paused by the US Food and Drug Administration (FDA) to clarify certain outstanding questions regarding the study drug. Diamyd Medical will be notified of which questions that are outstanding within 30 days.A so-called "partial clinical hold" means that the FDA has not yet approved all parts of a study submission. The FDA has informed that it does not yet have sufficient information on questions concerning the study drug. The FDA will within 30 days provide more details on what information needs to be supplemented in

Modus Therapeutics participates in FS markets Investment Meeting-Live on September 23rd

On Thursday, 23 September 2021 at 5.30 pm, Modus Therapeutics AB (“Modus”) will participate in FS Markets Investerarmötet-Live (Investment Meeting-Live). Modus CEO John Öhd will present the company and discuss upcoming plans.Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition. Investor Meeting-Live is a live webcast seminar. The presentation will be followed by a question-and-answer session where you can ask

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 500,000,000. Start date:                   22 September 2021 Maturity:                      22 November 2021 Coupon:                      0.54 % Organised by:             Handelsbanken Capital Markets          Orkla ASA Oslo, 17 September 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Change of TVO's Senior Vice President for Safety and Security Services

Teollisuuden Voima Oyj's (TVO) Senior Vice President for Safety and Security Services, Mikko Kosonen, has been appointed as a Corporate Advisor as of January 1, 2022, and he will retire during the summer 2022. M.Sc (Tech.), D.Sc (Tech.) Veli-Pekka Nurmi has been appointed as the new Senior Vice President for Safety and Security Services, and he will be transferring to the TVO Group from his position as Executive Director of the Safety Investigation Authority in Finland (OTKES). The appointment enters into force on January 1, 2022.Veli-Pekka Nurmi has a strong background in safety management

Trading update

Reference is made to the share buyback announcement of September 17, 2021. Atea is providing a trading update to ensure that the financial markets have current information on management’s expectations while the company executes the share buyback. Management estimates an EBIT in Q3 2021 of approximately MNOK 245 – 260, in line with financial estimates from analysts.  The longer term outlook is unchanged.  Further information on the business outlook can be found in the Q2 2021 financial report.  For more information, please contact:Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930

Initiation of share repurchase program

The Board of Directors of Atea ASA has resolved to initiate a share repurchase program. The share repurchase program is in accordance with the power of attorney granted to the Board by the Annual General Meeting of Atea ASA on April 29, 2021. The share repurchase program will be for a maximum consideration of NOK 100 million, and for a maximum of 520,000 shares. The program will commence on September 20 and continue until October 31, 2021 or until the maximum number of shares has been repurchased. Buyback transactions will be executed according to the market price on the Oslo Stock

Raisio plc: Managers´ transactions

Raisio plc    Managers´ transactions 17 September 2021 MANAGERS’ TRANSACTIONS Person subject to the notification requirementName: Saarinen, MikaPosition: Chief Financial OfficerIssuer: Raisio OyjLEI: 74370083282NHIP4QD02 Notification type: INITIAL NOTIFICATIONReference number: 74370083282NHIP4QD02_20210916135702_2____________________________________________ Transaction date: 2021-09-16Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009002943Nature of the transaction: ACQUISITION Transaction details(1): Volume: 719 Unit price: 3.51 EUR(2)

The Board of Betsson begins process to find a replacement for longtime CEO and founder Pontus Lindwall

The Board of Directors of Betsson AB (publ) concludes that Pontus Lindwall has completed the assignment "Back on Track", which is the program he was hired as CEO to implement in 2017. In the second quarter of 2021, Betsson reported its best quarter to date in terms of sales and earnings.The Board believes that Betsson is ready for further renewal in order to meet the challenges in an international environment, more regulated markets and take advantage of new opportunities. Against this background, the Board will begin the work of searching for the next generation of international leader to

There are no items matching the current filter
There are no more items matching the current filter
Back to top